Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

656

Participants

Timeline

Start Date

July 13, 2007

Primary Completion Date

August 1, 2009

Study Completion Date

August 20, 2009

Conditions
Migraine Disorders
Interventions
DRUG

Combination Tablet of Treximet (sumatriptan/naproxen sodium)

Combination Tablet of Treximet(sumatriptan/naproxen sodium)

Trial Locations (77)

7450

GSK Investigational Site, Ridgewood

10022

GSK Investigational Site, New York

10550

GSK Investigational Site, Mount Vernon

11803

GSK Investigational Site, Plainview

12206

GSK Investigational Site, Albany

13760

GSK Investigational Site, Endwell

14221

GSK Investigational Site, Williamsville

14226

GSK Investigational Site, Amherst

14609

GSK Investigational Site, Rochester

14642

GSK Investigational Site, Rochester

22902

GSK Investigational Site, Charlottesville

23510

GSK Investigational Site, Norfolk

27607

GSK Investigational Site, Raleigh

29651

GSK Investigational Site, Greer

30342

GSK Investigational Site, Atlanta

31405

GSK Investigational Site, Savannah

32504

GSK Investigational Site, Pensacola

33407

GSK Investigational Site, West Palm Beach

33470

GSK Investigational Site, Loxahatchee Groves

33701

GSK Investigational Site, St. Petersburg

34102

GSK Investigational Site, Naples

37203

GSK Investigational Site, Nashville

40004

GSK Investigational Site, Bardstown

42071

GSK Investigational Site, Murray

43081

GSK Investigational Site, Westerville

43205

GSK Investigational Site, Columbus

44195

GSK Investigational Site, Cleveland

45229

GSK Investigational Site, Cincinnati

46011

GSK Investigational Site, Anderson

48104

GSK Investigational Site, Ann Arbor

49008

GSK Investigational Site, Kalamazoo

49024

GSK Investigational Site, Protage

49079

GSK Investigational Site, Paw Paw

49083

GSK Investigational Site, Richland

55441

GSK Investigational Site, Plymouth

63141

GSK Investigational Site, St Louis

68130

GSK Investigational Site, Omaha

72205

GSK Investigational Site, Little Rock

72401

GSK Investigational Site, Jonesboro

73112

GSK Investigational Site, Oklahoma City

75230

GSK Investigational Site, Dallas

77058

GSK Investigational Site, Nassau Bay

78229

GSK Investigational Site, San Antonio

78626

GSK Investigational Site, Georgetown

79075

GSK Investigational Site, Plano

80045

GSK Investigational Site, Aurora

80909

GSK Investigational Site, Colorado Springs

84109

GSK Investigational Site, Salt Lake City

84121

GSK Investigational Site, Salt Lake City

85014

GSK Investigational Site, Phoenix

85234

GSK Investigational Site, Gilbert

87108

GSK Investigational Site, Albuquerque

89014

GSK Investigational Site, Henderson

90277

GSK Investigational Site, Redondo Beach

90404

GSK Investigational Site, Santa Monica

91325

GSK Investigational Site, Northridge

92037

GSK Investigational Site, La Jolla

92585

GSK Investigational Site, Sacramento

92618

GSK Investigational Site, Irvine

92647

GSK Investigational Site, Huntington Beach

92660

GSK Investigational Site, Newport Beach

92835

GSK Investigational Site, Fullerton

93720

GSK Investigational Site, Fresno

94109

GSK Investigational Site, San Francisco

94596

GSK Investigational Site, Walnut Creek

95628

GSK Investigational Site, Fair Oaks

95678

GSK Investigational Site, Roseville

95926

GSK Investigational Site, Chico

97210

GSK Investigational Site, Portland

97401

GSK Investigational Site, Eugene

98310

GSK Investigational Site, Bremerton

98801

GSK Investigational Site, Wenatchee

06118-3239

GSK Investigational Site, East Hartford

06824

GSK Investigational Site, Fairfield

08901

GSK Investigational Site, New Brunswick

08043

GSK Investigational Site, Vorhees

97504-8456

GSK Investigational Site, Medford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY